StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Incyte (INCY) PT Raised to $109 at BofA Securities
October 28, 2025 10:31 AM
BofA Securities analyst Tazeen Ahmad raised the price target on Incyte (NASDAQ: INCY) to $109.00 (from $104.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Form 8-K INCYTE CORP For: Oct 28
October 28, 2025 7:04 AM
Incyte (INCY) Tops Q3 EPS by 67c; raises guidance
October 28, 2025 7:02 AM
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
October 28, 2025 7:00 AM
Form 144 INCYTE CORP Filed by: Flannelly Barry P
October 27, 2025 4:21 PM
Incyte partners with Enable Injections for drug delivery system
October 27, 2025 7:30 AM
Incyte and Enable Injections Announce Strategic Partnership for enFuse® On-Body Delivery System
October 27, 2025 7:30 AM
Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura® (Ruxolitinib Cream) in Adults with Moderate Atopic Dermatitis
October 25, 2025 7:55 PM
Lilly's baricitinib shows hair regrowth in adolescents with alopecia areata
October 24, 2025 6:45 AM
Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
October 24, 2025 6:45 AM
